Generic names formulation

Classification Trade Name Generic Name Formulation Adult Analgesic Dosage (mg)... 

Generic Name Formulation Concentration Trade Name (Manufacturer)... 

Generic name Formulations (mg) Maximum daily dose (mg) Orthostatic hypotension Dizziness Tachycardia Blurred vision Dry mouth Memory loss Urinary retention Constipation EPS Prolactin elevation Sedation Weight gain Sweating Anxiety Darrhea Nausea ... 

Generic Name Brand Names Formulations Dosages Clinical Use... 

Dyes having the same Cl generic name but made by different manufacturers may also require different amounts of electrolyte to be added to the dyebath, according to the amount of electrolyte present in the commercial formulation. A typical instruction is to use from 0 to... 

Generic Name Trade Name Formulations Dosage and Administration Clinical Use Proposed Mechanism of Action... 

More than seventy years ago the impressive discovery was made that bioreduction of mannitol, glycerol and starch yields butanol. Fermentations in which butyric acid, butanol and acetone are formed from carbohydrates by different bacilli (butyl bacteria) belong in this group. The term butyl bacteria as a generic name for microbes producing the genetically related substances of the four-carbon series was proposed in 1921" and has been applied since then. The approximate course of these reactions is shown by the following formulations which, however, do not explain the mechanism ... 

Marketed name (generic name) [molecule type] Formulation type Manufacturer (dosage forms) Strengths or concentration (pH of formulation) Excipients Route of administration... 

Nocobactin NA is the generic name given to a series of compounds obtained after dissociation of a ferric complex isolated from the bacterium Nocardia as-teroides grown under iron-deficient conditions (97). Spectroscopic, degradative, and partial synthetic studies led to the formulation 187 for the compounds. The nocobactins are lipid-soluble ionophores whose function appears to be the transport of iron across the lipid-rich cell boundary of the producing organism. 

Protein transport between intracellular compartments is mediated by a mechanism that is well-conserved among all eukaryotes, from yeast to man. The transport mechanism involves carrier vesicles that bud from one organelle and fuse selectively to another. Specialized proteins are required for vesicle transport, docking, and fusion, and they have been generically named SNAREs (an acronym for soluble N-ethylma-leimide-sensitive fusion attachment protein receptor). SNAREs have been divided into those associated with the vesicle (termed v-SNAREs), and those associated with the target (termed t-SNAREs). The key protein, which led to the discovery of SNAREs was NSF, an ATPase found ubiquitously in all cells, and involved in numerous intracellular transport events. The subsequent identification of soluble proteins stably bound to NSF, the so-called SNARE complex, led to the formulation of the SNARE hypothesis, which posits that all intracellular fusion events are mediated by SNAREs (Rothman, 2002). 

Generic Name Trade Name Manufacturer Formulation and Concentration (%)... 

Proprietary Name Manufacturer Generic/ Concentration Formulation... 

As discussed in eariler, PPE is fabricated from a wide variety of polymeric materials by many processes. Glove materials, for example, are multicomponent formulations containing one or more polymers and copolymers, processing aids, stabilizers, fillers and so forth. Gloves are typically sold under the generic name of the principal polymer in the formulation (e.g., nitrile, butyl, etc.). However, the formulations for the products sold under one generic name will vary from manufacturer to manufacturer and, in some cases, within one manufacturer. 

Manufacturers of resins, colorants, inks, compounds, parts, molded components, container systems, and packaging operations all use Type 3 DMFs. Depending on the subject of the DMF, it should contain the following A short facility description, the formulation providing the trade name, the generic name. Code of Federal Regulations Title 21 indirect food additive reference or Food Contact Number, Chemical Abstract number, and references to other supporting DMFs, if applicable. The DMF should list... 

Name and quantity of each ingredient formulation to be broken down by listing each ingredient by generic name per unit dose. Where applicable, company code names for ready identification can be used. 

Generic name (originator) Brand name Form Formulation components (mg/mL) Melting point of active Log K(octanol-water) of active... 

Drug (generic name) Brand name Formulation pH Solution components after reconstitution (mg/mL) Melting point (°C)/ log P (neutral) Administration routes/dosage... 

Topical corticosteroids have been the standard approach for treating the inflammation and pruritus of AD. Typically used in shortterm reactive treatment of acute flare-ups, topical corticosteroids must be supplemented with emollients. Clinicians unfamiliar with topical corticosteroids find them a challenge to use, due to the numerous types, strengths, generic versus brand name formulations, and the wide variety of ways to use the products. The corticosteroids are ranked according to potency depending on vasoconstrictor assays (see Table 96-4 in Chap. 96, on psoriasis). Most commonly, the highest-... 

---